Get started
Author

Andreas Muhs

Mapping microglia states in the human brain through the integration of high-dimensional techniques
2019 · Roman Sankowski, Chotima Böttcher, et al. · Nature Neuroscience · 448
Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
2013 · Clara Theunis, Natalia Crespo-Biel, et al. · PLoS ONE · 274
PDF
Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
2019 · Heiko Kroth, Felix Oden, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 226
PDF
Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice
2007 · Andreas Muhs, David T. Hickman, et al. · Proceedings of the National Academy of Sciences · 182
Aβ42 Neurotoxicity Is Mediated by Ongoing Nucleated Polymerization Process Rather than by Discrete Aβ42 Species
2010 · Asad Jan, Oskar Adolfsson, et al. · Journal of Biological Chemistry · 179
PDF
Cell Transplantation Improves Ventricular Function After a Myocardial Infarction
2005 · Byung-Ok Kim, Hai Tian, et al. · Circulation · 156
Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement
2016 · Seung-Hye Lee, Claire E. Le Pichon, et al. · Cell Reports · 127
PDF
Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin
2016 · Mark Ultsch, Bing Li, et al. · Scientific Reports · 125
PDF
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer’s disease
2021 · Gai Ayalon, Seung-Hye Lee, et al. · Science Translational Medicine · 112
Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors
2012 · Wolfgang Froestl, Andreas Muhs, et al. · Journal of Alzheimer s Disease · 95
Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases
2011 · David T. Hickman, María Pilar López-Deber, et al. · Journal of Biological Chemistry · 84
PDF
BACE-1 is expressed in the blood–brain barrier endothelium and is upregulated in a murine model of Alzheimer’s disease
2015 · Kavi Devraj, Slobodan Poznanovic, et al. · Journal of Cerebral Blood Flow & Metabolism · 70
Discovery and Structure Activity Relationship of Small Molecule Inhibitors of Toxic β-Amyloid-42 Fibril Formation
2012 · Heiko Kroth, Annalisa Ansaloni, et al. · Journal of Biological Chemistry · 61
PDF
Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects
2017 · Aurélien Lathuilière, Pamela Valdés, et al. · Scientific Reports · 56
PDF
Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression
2018 · Hsu-Hsin Chen, Peter Liu, et al. · Scientific Reports · 53
PDF
An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome
2016 · Pavel V. Belichenko, Rime Madani, et al. · PLoS ONE · 50
PDF
Dynamic Nuclear Polarization NMR Spectroscopy: Revealing Multiple Conformations in Lipid‐Anchored Peptide Vaccines
2013 · Eline J. Koers, Maria Pilar López‐Deber, et al. · Angewandte Chemie International Edition · 46
TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell–independent isotype switch in mice
2012 · Maria Pihlgren, Alberto B. Silva, et al. · Blood · 45
PDF
Preclinical Evaluation of Inducible Nitric Oxide Synthase Lipoplex Gene Therapy for Inhibition of Stent-Induced Vascular Neointimal Lesion Formation
2003 · Andreas Muhs, Bernd Heublein, et al. · Human Gene Therapy · 42
Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes
2013 · Wolfgang Froestl, Andreas Muhs, et al. · Journal of Alzheimer s Disease · 31
Discovery and characterization of novel indole and 7-azaindole derivatives as inhibitors of β-amyloid-42 aggregation for the treatment of Alzheimer’s disease
2017 · Nampally Sreenivasachary, Heiko Kroth, et al. · Bioorganic & Medicinal Chemistry Letters · 29
Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs
2013 · Wolfgang Froestl, Andrea Pfeifer, et al. · Journal of Alzheimer s Disease · 27
Human genome–guided identification of memory-modulating drugs
2013 · Andreas Papassotiropoulos, Christiane Gerhards, et al. · Proceedings of the National Academy of Sciences · 26
Development of a Small D-Enantiomeric Alzheimer’s Amyloid-β Binding Peptide Ligand for Future In Vivo Imaging Applications
2012 · Susanne Aileen Funke, Dirk Bartnik, et al. · PLoS ONE · 26
PDF
A C‐Linked Disaccharide Analogue of Thomsen–Friedenreich Epitope Induces a Strong Immune Response in Mice
2012 · Loay Awad, Rime Madani, et al. · Chemistry - A European Journal · 25
Works count: 61
Citation count: 2,801
H-index: 25
I10-index: 33
Year
Topic
Type